{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/raynauds-phenomenon/diagnosis/differential-diagnosis/","result":{"pageContext":{"chapter":{"id":"ab1aab22-cf2f-584c-b073-a5bba7ae4c6d","slug":"differential-diagnosis","fullItemName":"Differential diagnosis","depth":2,"htmlHeader":"<!-- begin field 7cc61eb7-80d1-415e-ab9a-ab5d00b588c3 --><h2>What else might it be?</h2><!-- end field 7cc61eb7-80d1-415e-ab9a-ab5d00b588c3 -->","summary":"","htmlStringContent":"<!-- begin item 42fd5dc4-1e2f-4089-90b1-ab5d00b5887e --><!-- begin field 526f5fff-f500-45cf-8f98-ab5d00b588c3 --><ul><li><strong>Raynaud's phenomenon may present with similar clinical features to:</strong><ul><li>Chilblains (perniosis) — erythematous, itchy swellings on fingers and toes following cold exposure.</li><li>Acrocyanosis — continuous blueness of the hands or feet aggravated by cold.</li><li>Erythromelalgia — painful redness of the hands or feet caused by paroxysmal dilatation of blood vessels.</li><li>Occlusive vascular disease — for example embolism.</li><li>Vasculitis.</li><li>Haematological malignancy, cryodiseases and hyperviscoscity syndromes.</li><li>Livedo reticularis — mottled, cyanotic discolouration of the skin that can be widespread or localized, and physiological or pathological in nature.</li><li>Peripheral nerve injury.</li><li>Reflex sympathetic dystrophy (shoulder–hand syndrome) — diffuse persistent pain in an extremity, often associated with vasomotor changes and following an injury.</li></ul></li></ul><!-- end field 526f5fff-f500-45cf-8f98-ab5d00b588c3 --><!-- end item 42fd5dc4-1e2f-4089-90b1-ab5d00b5887e -->","topic":{"id":"255ee7a1-48e0-54c2-a732-4e03fba17a60","topicId":"e0f3a627-69e7-4258-bfd3-06ad68e3ba94","topicName":"Raynaud's phenomenon","slug":"raynauds-phenomenon","lastRevised":"Last revised in February 2020","chapters":[{"id":"0209e319-b6f4-5f73-ae5c-6afd753453ea","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"9bb70ded-aa7a-5909-9d84-111f559bccc8","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"47c14b87-688e-5e8e-af1c-e6614c461561","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"ad9e53ac-9556-5bdd-aa04-09e22fccd689","slug":"changes","fullItemName":"Changes"},{"id":"aa95064f-a6c4-5317-a6ec-33fca3665fa5","slug":"update","fullItemName":"Update"}]},{"id":"0346daa7-fb38-5512-b2c8-7f0d5d4b7c91","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"074b9165-8cc3-56b5-a9fa-483516a026aa","slug":"goals","fullItemName":"Goals"},{"id":"dadcf48d-9a98-54cf-baab-c0b65179b8f1","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"d272b294-ed60-5488-8640-d756cbe670a3","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"9dcdeaed-4201-583c-a5a9-5dcb4ead9acb","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"4c107602-0bb8-52d9-b277-5639494a105e","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"72ac11d0-1027-5c50-ae82-9ae1e1bf92b7","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"0559a1bc-62df-54ef-846b-db71b06fbe87","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"2ec7ca08-f644-50e8-b54e-c6378c7053b0","slug":"definition","fullItemName":"Definition"},{"id":"951db58c-3bcb-56ef-be5f-1e0fd9fdbd81","slug":"causes-of-or-diseases-associated-with-raynauds-phenomenon","fullItemName":"Causes of, or diseases associated with Raynaud's phenomenon:"},{"id":"b9b9e063-b592-5419-8f15-8f350c8de255","slug":"prevalence-incidence","fullItemName":"Prevalence and incidence"},{"id":"16789ea7-d3e6-5c24-a51f-e9f57845b88b","slug":"prognosis","fullItemName":"Prognosis"},{"id":"b914d639-5ff2-526f-86e9-1280331ece9b","slug":"complications","fullItemName":"Complications"}]},{"id":"1478d9b3-2ba3-5103-9fab-2a67d58f88f4","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"509776f6-588e-5896-9432-bf45ef2f63e1","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"9a10980a-a167-52bd-9991-be6f6cd68c50","slug":"assessment","fullItemName":"Assessment"},{"id":"ab1aab22-cf2f-584c-b073-a5bba7ae4c6d","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"143745f3-74bd-57da-b042-3dd311837d98","fullItemName":"Management","slug":"management","subChapters":[{"id":"f6006983-20db-5702-8a8c-9763d45ab3cf","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"ede08fed-d06c-5c6c-9c34-9ada648e6c09","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"1c7cb268-2a82-5737-b0ee-332487a61ea1","slug":"nifedipine","fullItemName":"Nifedipine"}]},{"id":"f6403106-c5ec-5705-bdcf-a225c5de60f9","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"8a93fc9c-f20c-58a4-a5db-33420cd3b27a","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"e2a1391d-6c3d-5d36-b072-abc59f16980c","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"bfa3b4f4-feec-59d7-9574-f36fc1bcf5cd","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"18ed7dfb-e0e7-5be9-9a57-0ab24f1666c5","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"2bf5741c-d447-5f96-8155-861976265e79","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"52d565ac-2dac-556a-9bc8-c5c8946df2ed","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"1b7e64ea-3359-5d63-93ff-6b661619a25e","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"1478d9b3-2ba3-5103-9fab-2a67d58f88f4","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"946ee011-699c-53a1-be9f-4c5c70e2efc1","slug":"basis-for-recommendation-c4f","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field d962d8ed-edb3-4574-8853-ab5d00b93881 --><h3>Basis for recommendation</h3><!-- end field d962d8ed-edb3-4574-8853-ab5d00b93881 -->","summary":null,"htmlStringContent":"<!-- begin item c4f9dd96-a7f1-4542-b515-ab5d00b937d5 --><!-- begin field 3df9b73f-6bb5-4c7e-8ed0-ab5d00b93881 --><p>The information on differential diagnoses is based on expert opinion in clinical guidelines <em>ESVM guidelines - the diagnosis and management of Raynaud's</em> phenomenon [<a class=\"bibliography-reference internal-reference\" href=\"/topics/raynauds-phenomenon/references/\">Belch, 2017</a>], review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/raynauds-phenomenon/references/\">Linnemann, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/raynauds-phenomenon/references/\">Wigley, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/raynauds-phenomenon/references/\">Herrick, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/raynauds-phenomenon/references/\">Shapiro, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/raynauds-phenomenon/references/\">BMJ Best Practice, 2019</a>] and from an external reviewer of this CKS topic.</p><!-- end field 3df9b73f-6bb5-4c7e-8ed0-ab5d00b93881 --><!-- end item c4f9dd96-a7f1-4542-b515-ab5d00b937d5 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}